Cargando…
Toward a gene therapy for neurological and somatic MPSIIIA
Mucopolysaccharidosis Type IIIA (MPSIIIA) represents an unmet medical need. MPSIIIA shares with many other lysosomal storage disorders (LSD) the characteristic of being a severe neurodegenerative disease accompanied by mild somatic involvement. Thus, the main target organ for the development of new...
Autores principales: | Haurigot, Virginia, Bosch, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927492/ https://www.ncbi.nlm.nih.gov/pubmed/25003015 http://dx.doi.org/10.4161/rdis.27209 |
Ejemplares similares
-
A step closer toward therapies for p63-related disorders
por: Zhou, Huiqing, et al.
Publicado: (2013) -
Problems and solutions for the analysis of somatic CAG repeat expansion and their relationship to Huntington's disease toxicity
por: Budworth, Helen, et al.
Publicado: (2016) -
Addendum: da Silva, J.L.F.; et al. The Lisbon Supramolecular Green Story: Mechanochemistry towards New Forms of Pharmaceuticals. Molecules 2020, 25, 2705
por: da Silva, João Luís Ferreira, et al.
Publicado: (2021) -
Gene therapy for Wiskott-Aldrich Syndrome—Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis
por: Braun, Christian Joerg, et al.
Publicado: (2014) -
Toward a porcine in vivo model to analyze the pathogenesis of TLR5-dependent enteropathies
por: Pieper, Robert, et al.
Publicado: (2020)